Furthermore, we found that baicalin could inhibit cerebral ischemia-induced activation of the NFκB/CCL2/CCR2 pathway via targeting NFκB activation and CCL2/CCR2 interaction. The gene discussed is NFKB1; the disease is Cerebral ischemia.